Oncology Medical News about metastatic breast cancer

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies
British Journal of Cancer, 10/26/09

Toi M et al. – Lapatinib monotherapy had shown anti–tumour activity in Japanese patients with HER2–positive MBC that relapsed after trastuzumab–based therapy, including those with brain metastases. Patients benefiting from lapatinib may have biomarker profiles differing from that reported for trastuzumab.

<< Previous
Long-Term Evaluation of Ifosfamide-Related Nephrotoxicity in...

Next >>
HuR modulates gemcitabine efficacy: new perspectives in...